Rigor Is Needed When Making Comparative Analyses of Biologics in Severe Asthma

Am J Respir Crit Care Med. 2018 Jun 1;197(11):1508-1510. doi: 10.1164/rccm.201712-2455LE.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Asthma*
  • Biological Products*
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Biological Products
  • reslizumab
  • mepolizumab